Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014461
Filing Date
2022-08-04
Accepted
2022-08-04 07:05:38
Documents
83
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q omga-20220630.htm   iXBRL 10-Q 3231404
2 EX-31.1 omga-ex31_1.htm EX-31.1 19290
3 EX-31.2 omga-ex31_2.htm EX-31.2 19267
4 EX-32.1 omga-ex32_1.htm EX-32.1 11699
5 EX-32.2 omga-ex32_2.htm EX-32.2 11405
  Complete submission text file 0000950170-22-014461.txt   10447790

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT omga-20220630_def.xml EX-101.DEF 237959
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT omga-20220630_lab.xml EX-101.LAB 544366
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT omga-20220630_pre.xml EX-101.PRE 406756
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT omga-20220630_cal.xml EX-101.CAL 54830
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT omga-20220630.xsd EX-101.SCH 71039
77 EXTRACTED XBRL INSTANCE DOCUMENT omga-20220630_htm.xml XML 1737427
Mailing Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 (617) 949-4360
Omega Therapeutics, Inc. (Filer) CIK: 0001850838 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40657 | Film No.: 221134604
SIC: 2836 Biological Products, (No Diagnostic Substances)